Navigation Links
Non-Surgical Clubfoot Treatments Bring High Level of Success
Date:11/3/2008

f the Internet. Parents began researching treatment options for their children and found information about the Ponseti and French methods, so interest in these treatments began to spread, and we saw how successful they can be."

In the Ponseti method, the foot is stretched and then placed in a cast extending above the knee. Each week, the orthopaedist removes the cast, stretches the foot further toward the correct position, and recasts it. After three to five casts, the foot is straightened but the heel cord (or Achilles tendon) often remains too tight. The heel cord is then surgically lengthened so the foot can be placed in the normal position. A final cast is worn for three weeks as the heel cord mends. After the cast is removed, the child must then wear a brace full-time for three months and then at night for about two years.

The French functional method consists of daily stretching, exercise, massage, and immobilization of the foot with nonelastic tape to slowly move the foot to the correct position. These therapy sessions are performed primarily by a physical therapist for the first three months, when most of the improvement occurs, but parents receive training during this time in order to perform some of the treatments at home. The taping and splinting continues until the child is two years old. It is important to note that this method is currently not available in many parts of the United States.

In the study, parents were given the choice of the two treatment methods. More than twice as many parents chose the Ponseti Method, in part because of the difficulty for some parents to make the daily visits to the hospital required by the French Functional Method. The average severity of the condition within both groups was about the same. The patients were then followed through the next two years of treatment.

The results were similar:

-- In the Ponseti group:

-- 94.4 percent achieved satisfactory initial correct
'/>"/>

SOURCE American Academy of Orthopaedic Surgeons
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Dr. Lisa Zdinak Announces, CO2TouchTM Brazilian Carboxytherapy - New Technology for Non-Surgical Treatment of Stretch Marks, Cellulite and Dark Undereye Circles
2. Non-Surgical Approach Can Treat Lung Cancers
3. New Non-Surgical Stem-Cell Procedure Relieves Degenerative Joint Disease
4. Newly Published Study in Leading Medical Journal Further Confirms the Brava Systems Non-Surgical Breast Enhancement Effectiveness
5. Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat
6. Gene Plays Key Role in Clubfoot
7. Cancer Patients in Southeastern Florida Now Benefiting From RapidArc(TM) Radiotherapy Treatments
8. If metastasectomy should be performed before other treatments
9. Two Preemie Treatments May Not Help
10. Top Indian Cancer Hospital to Introduce Advanced Radiosurgery Treatments With Novalis Tx from Varian Medical Systems and BrainLAB
11. MicroRNAs make for safer cancer treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2Health News:Help Young Cancer Patients Enjoy Christmas This Season 2Health News:The NHS to Improve Patient Care by Better Engaging Staff 2
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5The Worlds Only Online Marketplace Dedicated to Buying and Selling Gently Used and New Special Needs Equipment 3A DifferentNeedz com 5284 1The Worlds Only Online Marketplace Dedicated to Buying and Selling Gently Used and New Special Needs Equipment 3A DifferentNeedz com 5284 2Marc J Fagel of the U S Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech Pharma Finance and Accounting Forum in San Fra 5282 1Marc J Fagel of the U S Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech Pharma Finance and Accounting Forum in San Fra 5282 2Mike Fuljenz and Universal Coin 26amp 3B Bullion Sponsors the NRA Eddie Eagle GunSafe Program 14381 1Mike Fuljenz and Universal Coin 26amp 3B Bullion Sponsors the NRA Eddie Eagle GunSafe Program 14381 2